GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Non-Current Assets of $235.7 million for Q1 2026, up 6.83% year-over-year from $220.6 million in Q1 2025, and down 7.73% quarter-over-quarter from $255.4 million in Q4 2025.
GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Non-Current Assets for 7 consecutive years, with $235.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 6.83% year-over-year to $235.7 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 12.86% YoY), while the FY2025 annual figure was $255.4 million, up 15.36% from the prior year.
- Non-Current Assets slipped to $235.7 million in Q1 2026 per WGS's latest filing, from $255.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $530.6 million in Q2 2022 and bottomed at $107.2 million in Q1 2022.
- Historically, Non-Current Assets has averaged $269.8 million across 5 years, with a median of $245.5 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 705.55% — and 2023, when it slumped 53.01%.
- GeneDx Holdings' Non-Current Assets stood at $278.3 million in 2022, then slipped by 15.06% to $236.4 million in 2023, then decreased by 6.35% to $221.4 million in 2024, then gained by 15.36% to $255.4 million in 2025, then declined by 7.73% to $235.7 million in 2026.
- Business Quant data shows WGS's Non-Current Assets at $235.7 million in Q1 2026, $255.4 million in Q4 2025, and $256.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 1.93 Bn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 14.10 Bn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.95 Bn | 78.24 Mn | 235.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 235.13 Mn |
| Mar 31, 2026 | 235.67 Mn |
| Dec 31, 2025 | 255.42 Mn |
| Sep 30, 2025 | 256.32 Mn |
| Jun 30, 2025 | 259.03 Mn |
| Mar 31, 2025 | 220.61 Mn |
| Dec 31, 2024 | 221.41 Mn |
| Sep 30, 2024 | 222.83 Mn |
| Jun 30, 2024 | 226.93 Mn |
| Mar 31, 2024 | 231.10 Mn |
| Dec 31, 2023 | 236.42 Mn |
| Sep 30, 2023 | 245.47 Mn |
| Jun 30, 2023 | 263.11 Mn |
| Mar 31, 2023 | 272.95 Mn |
| Dec 31, 2022 | 278.32 Mn |
| Sep 30, 2022 | 522.36 Mn |
| Jun 30, 2022 | 530.58 Mn |
| Mar 31, 2022 | 107.25 Mn |
| Dec 31, 2021 | 70.55 Mn |
| Sep 30, 2021 | 64.85 Mn |